Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JULY 26, 2013 FBO #4262
SOLICITATION NOTICE

68 -- Purchase of protein biomarkers for assessing exposure to cholinesterase inhibitors

Notice Date
7/24/2013
 
Notice Type
Presolicitation
 
NAICS
611310 — Colleges, Universities, and Professional Schools
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
2013-Q-15943
 
Archive Date
8/23/2013
 
Point of Contact
Leslie D. Jones, Phone: 7704882042, Vallerie M Redd, Phone: 770-488-2845
 
E-Mail Address
jxy6@cdc.gov, gfj3@cdc.gov
(jxy6@cdc.gov, gfj3@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
The Centers for Disease Control and Prevention (CDC), National Center for Environmental Health (NCEH), intends to award a sole source contract to the University of Washington Medical School, Department of Medicine (Division of Medical Genetics) and Genome Sciences, Organophosphrous Exposure Laboratory, Box 357720, Seattle, WA 98195-7720 for the acquisition of the development of new, long-term protein biomarkers of exposure to cholinesterase inhibitors for incorporation into CDC analytical methods. The statutory authority for this sole source acquisition is 10 U.S.C 2304(c)(1) in accordance with FAR Part 6.302-1- only one responsible source and no other supplies or services will satisfy the agency requirement. The NAICS code for this procurement is 611310, Colleges, Universities, and Professional Schools. The period of performance for this procurement is 12 months. The Organophosphorus Exposure Laboratory of the University of Washington has access to a wide variety of human clinical samples including serum/plasma and whole blood inhibited by organophosphorus compounds including nerve agents, jet engine lubricant additives, and pesticides; such access is an absolute requirement for protein biomarker discovery. Also, the University of Washington is a respected, international leader in the field of cholinesterases and has a proven track record for developing new biomarkers of exposure to cholinesterase inhibitors. The laboratory has unique experience in assessing cholinesterase inhibitor effects on enzymatic activity and is the only lab in the world known to have the capability to use analysis of blood spots for assessing exposure to OP compounds. The University of Washington is the only one capable of testing any new potential biomarkers using the same immunomagnetic separation (IMS) liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach that is utilized in CDC's clinical assays for assessing exposure to OPNAs. The University of Washington has access to state of the art high resolution tandem mass spectrometers and detailed experience using this equipment for discovery based and quantitative proteomics. The University of Washington is the primary contributor to biomarker discovery in this field and is the only resource that satisfies all of the requirements for this request. As a result of this synopsis, no competitive solicitation will be posted on FedBizOpps. We will issue only one solicitation to the University of Washington Medical School, Department of Medicine (Division of Medical Genetics) and Genome Sciences, Organophosphrous Exposure Laboratory. However, all responsible sources that believe they can meet these requirements may submit their capabilities/qualifications statement to provide the services to Leslie Jones via email ONLY at jxy6@cdc.gov with the solicitation number 2013-Q-15943 referenced in the subject line NO LATER THAN August 8, 2013. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2013-Q-15943 /listing.html)
 
Place of Performance
Address: Contractor Facility, United States
 
Record
SN03126506-W 20130726/130725000022-57d2a8f991e4d63bab40002235a60ddd (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.